Publications by authors named "Peter Demin"

Claim this Profile
D
Development of a hydrophilic interaction high-performance liquid chromatography method for the determination of glycine in formulations of therapeutic immunoglobulins.
Olga Rounova, Peter Demin, Mikhail Korotkov, Victoriya Malkova, Olga Ustinnikova

Anal Bioanal Chem· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alterations in eicosanoid levels during U937 bcl-xL tumour growth suppression and recovery in NU/NU mice in vivo-Involvement of phospholipase A2.
Cecil R Pace-Asciak, Xiang Li, Denis Reynaud, Na Qiao, Peter Demin

Prostaglandins Other Lipid Mediat· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tyrenes: synthesis of new antiproliferative compounds with an extended conjugation.
Peter Demin, Olga Rounova, Thomas Grunberger, Lorand Cimpean, Nigel Sharfe

Bioorg Med Chem· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of acute lymphoblastic and myeloid leukemias by a novel kinase inhibitor.
Thomas Grunberger, Peter Demin, Olga Rounova, Nigel Sharfe, Lorand Cimpean

Blood· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The thromboxane receptor antagonist PBT-3, a hepoxilin stable analog, selectively antagonizes the TPalpha isoform in transfected COS-7 cells.
Na Qiao, Denis Reynaud, Peter Demin, Perry V Halushka, Cecil R Pace-Asciak

J Pharmacol Exp Ther· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepoxilin analogs inhibit bleomycin-induced pulmonary fibrosis in the mouse.
Robert P Jankov, Xiaoping Luo, Peter Demin, Rukshana Aslam, Vicky Hannam

J Pharmacol Exp Ther· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new family of thromboxane receptor antagonists with secondary thromboxane synthase inhibition.
Cecil R Pace-Asciak, Denis Reynaud, Peter Demin, Rukshana Aslam, Andrea Sun

J Pharmacol Exp Ther· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis